NAD+ (nicotinamide adenine dinucleotide) has gone from being a metabolic player to a crucial coenzyme required by sirtuins to help with longevity. Unfortunately, NAD+ levels decline with age, and this is associated with cancer, diabetes, neurodegenerative disorders, and other age-related diseases. New findings published in Nature Metabolism on Nov 2020 identified “inflammaging” (age-related chronic inflammation) and cellular senescence as behind NAD+ decline.
For more information, contact us at 859-721-1414 or myhealth@prevmedheartrisk.com. Also, check out the following resources: